Chk1 suppresses bypass of mitosis and tetraploidization in p53-deficient cancer cells

被引:10
|
作者
Wilsker, Deborah [2 ]
Chung, Jon H. [1 ]
Bunz, Fred [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA
[2] NCI, Mol Radiat Therapeut Branch, SAIC Frederick, Frederick, MD 21701 USA
关键词
p53; Chk1; tetraploid; mitosis; DNA-DAMAGE CHECKPOINT; CHROMOSOMAL INSTABILITY; GENETIC INSTABILITY; KINASE; ATR; PHOSPHORYLATION; PROTEIN; REPLICATION; INACTIVATION; INHIBITION;
D O I
10.4161/cc.19944
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Many cancer cells are unable to maintain a numerically stable chromosome complement. It is well established that aberrant cell division can generate progeny with increased ploidy, but the genetic factors required for maintenance of diploidy are not well understood. Using an isogenic model system derived by gene targeting, we examined the role of Chk1 in p53-proficient and -deficient cancer cells. Targeted inactivation of a single CHK1 allele in stably diploid cells caused an elevated frequency of mitotic bypass if p53 was naturally mutated or experimentally disrupted by homologous recombination. CHK1-haploinsufficient, p53-deficient cells frequently underwent sequential rounds of DNA synthesis without an intervening mitosis. These aberrant cell cycles resulted in whole-genome endoreduplication and tetraploidization. The unscheduled bypass of mitosis could be suppressed by targeted reversion of a p53 mutation or by exogenous expression of Cdk1. In contrast, the number of tetraploid cells was not increased in isogenic cell populations that harbor hypomorphic ATR mutations, suggesting that suppression of unscheduled mitotic bypass is a distinct function of Chk1. These results are consistent with a recently described role for Chk1 in promoting the expression of genes that promote cell cycle transitions and demonstrate how Chk1 might prevent tetraploidization during the cancer cell cycle.
引用
收藏
页码:1564 / 1572
页数:9
相关论文
共 50 条
  • [1] Chk1 suppresses bypass of mitosis and tetraploidization in p53-deficient cells
    Wilsker, Deborah F.
    Chung, Jon H.
    Bunz, Fred
    CANCER RESEARCH, 2011, 71
  • [2] Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics
    Chen, Zehan
    Xiao, Zhan
    Gul, Wen-zhen
    Xue, John
    Bui, Mai H.
    Kovar, Peter
    Li, Gaoquan
    Wang, Gary
    Tao, Zhi-Fu
    Tong, Yunsong
    Lin, Nan-Horng
    Sham, Hing L.
    Wang, Jean Y. J.
    Sowin, Thomas J.
    Rosenberg, Saul H.
    Zhang, Haiying
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (12) : 2784 - 2794
  • [3] Chk1 inhibition-induced BRCAness synergizes with olaparib in p53-deficient cancer cells
    Zhao, Yang
    Zhou, Kehui
    Xia, Xiangyu
    Guo, Yajie
    Tao, Li
    CELL CYCLE, 2023, 22 (02) : 200 - 212
  • [4] Targeting the Chk1/Cdc25A pathway in p53-deficient tumors
    Piwnica-Worms, H.
    Ma, C.
    Cai, S.
    Ryan, C.
    Guo, Z.
    Li, S.
    Ellis, M.
    EJC SUPPLEMENTS, 2010, 8 (07): : 81 - 81
  • [5] DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53-deficient pancreatic cancer cells
    Jing, Wei
    Song, Na
    Liu, Yunpeng
    Qu, Xiujuan
    Hou, Kezuo
    Yang, Xianghong
    Che, Xiaofang
    MOLECULAR MEDICINE REPORTS, 2018, 17 (01) : 117 - 124
  • [6] CHK1 inhibition enhances chemosensitivity of p53 deficient osteosarcoma cells
    Xu, Gufeng
    Wang, Hongmei
    Rainusso, Nino C.
    Flores, Ricardo J.
    Triche, Timothy
    Man, Tsz-Kwong
    Lau, Ching C.
    CANCER RESEARCH, 2011, 71
  • [7] Chk'ing p53-deficient breast cancers
    Schoppy, David W.
    Brown, Eric J.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (04): : 1202 - 1205
  • [8] Natural pentacyclic triterpenoid from Pristimerin sensitizes p53-deficient tumor to PARP inhibitor by ubiquitination of Chk1
    Tao, Li
    Xia, Xiangyu
    Kong, Shujing
    Wang, Tingye
    Fan, Fangtian
    Wang, Weimin
    PHARMACOLOGICAL RESEARCH, 2024, 201
  • [9] Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling
    Jurvansuu, Jaana
    Fragkos, Michalis
    Ingemarsdotter, Carin
    Beard, Peter
    JOURNAL OF MOLECULAR BIOLOGY, 2007, 372 (02) : 397 - 406
  • [10] Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
    Ma, Cynthia X.
    Cai, Shirong
    Li, Shunqiang
    Ryan, Christine E.
    Guo, Zhanfang
    Schaiff, W. Timothy
    Lin, Li
    Hoog, Jeremy
    Goiffon, Reece J.
    Prat, Aleix
    Aft, Rebecca L.
    Ellis, Matthew J.
    Piwnica-Worms, Helen
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (04): : 1541 - 1552